We are live on ! Find out more
WST icon

West Pharmaceutical
WST

573 hedge funds and large institutions have $18.8B invested in West Pharmaceutical in 2020 Q3 according to their latest regulatory filings, with 101 funds opening new positions, 199 increasing their positions, 210 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more call options, than puts

Call options by funds: $20M | Put options by funds: $6.87M

110% more first-time investments, than exits

New positions opened: 101 | Existing positions closed: 48

19% more capital invested

Capital invested by funds: $15.8B → $18.8B (+$2.98B)

10% more funds holding

Funds holding: 523 → 573 (+50)

0% more funds holding in top 10

Funds holding in top 10: 9 → 9 (0)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 210

1.26% less ownership

Funds ownership: 94.11% → 92.85% (-1.3%)

Holders
573
Holders Change
+50
Holders Change %
+9.56%
% of All Funds
11.56%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.18%
New
101
Increased
199
Reduced
210
Closed
48
Calls
$20M
Puts
$6.87M
Net Calls
+$13.1M
Net Calls Change
+$2.64M

Top Buyers

1
Invesco
Invesco
Georgia
+$123M
2
Goldman Sachs
Goldman Sachs
New York
+$114M
3
BlackRock
BlackRock
New York
+$70.7M
4
APG Asset Management
APG Asset Management
Netherlands
+$68.2M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$58.8M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$223M
2
JP Morgan Chase
JP Morgan Chase
New York
-$119M
3
Wells Fargo
Wells Fargo
California
-$55.3M
4
Bessemer Group
Bessemer Group
New Jersey
-$54.6M
5
WCM Investment Management
WCM Investment Management
California
-$49.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.37B -$3.41M -12,897 -0.1%
BlackRock
2
BlackRock
New York
$1.91B +$70.7M +267,185 +4%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$1.22B -$223M -842,293 -16%
Franklin Resources
4
Franklin Resources
California
$1.08B -$44.2M -166,984 -4%
State Street
5
State Street
Massachusetts
$957M +$1.36M +5,132 +0.1%
Neuberger Berman Group
6
Neuberger Berman Group
New York
$527M -$6.48M -24,500 -1%
Invesco
7
Invesco
Georgia
$422M +$123M +462,972 +43%
BAMCO Inc
8
BAMCO Inc
New York
$396M -$351K -1,328 -0.1%
WCM Investment Management
9
WCM Investment Management
California
$377M -$49.4M -186,749 -12%
Artisan Partners
10
Artisan Partners
Wisconsin
$373M +$213K +806 +0.1%
Goldman Sachs
11
Goldman Sachs
New York
$367M +$114M +432,092 +48%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$334M +$2.88M +10,881 +0.9%
DCP
13
Durable Capital Partners
Maryland
$304M -$35.7M -135,073 -11%
Brown Advisory
14
Brown Advisory
Maryland
$268M +$31.8M +120,055 +14%
Capital Research Global Investors
15
Capital Research Global Investors
California
$242M -$33.4M -126,170 -13%
Northern Trust
16
Northern Trust
Illinois
$238M +$2.16M +8,149 +1%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$221M +$58.8M +222,194 +38%
Norges Bank
18
Norges Bank
Norway
$214M +$12.1M +45,750 +6%
N
19
Nuveen
North Carolina
$206M -$725K -2,741 -0.4%
Bank of America
20
Bank of America
North Carolina
$187M +$25.3M +95,427 +16%
Janus Henderson Group
21
Janus Henderson Group
United Kingdom
$185M +$11.4M +43,155 +7%
Massachusetts Financial Services
22
Massachusetts Financial Services
Massachusetts
$181M +$45.6M +172,414 +35%
AllianceBernstein
23
AllianceBernstein
Tennessee
$171M -$6.48M -24,499 -4%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$169M +$1.52M +5,760 +0.9%
Victory Capital Management
25
Victory Capital Management
Texas
$164M -$13.1M -49,624 -8%
1
2 3 4 5

WST Hedge Fund Activity: Q3 2020 in Review

573 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2020, worth a combined $18.8B — up 19% from $15.8B a quarter earlier.

Buyers outnumbered sellers: 101 funds opened new WST positions and 48 closed out — a net gain of 53 holders — while 199 added to existing stakes and 210 trimmed.

The largest buyer was Invesco, adding an estimated $123M. The largest seller was T. Rowe Price Associates, cutting an estimated $223M.

  • 573 institutional investors held West Pharmaceutical (WST) as of Q3 2020, up from 523 in Q2 2020.
  • Funds reported $18.8B of West Pharmaceutical stock for Q3 2020, up 19% quarter-over-quarter.
  • 101 funds opened new West Pharmaceutical positions in Q3 2020 and 48 closed out, a net change of +53 holders.
  • The largest West Pharmaceutical buyer in Q3 2020 was Invesco, an estimated $123M added.
  • The largest West Pharmaceutical seller in Q3 2020 was T. Rowe Price Associates, an estimated $223M sold.

Based on aggregated 13F filings for Q3 2020.